Skip to main content
PMC home page
Arrhythmia & Electrophysiology Review logoLink to Arrhythmia & Electrophysiology Review
editorial
. 2024 Mar 13;13:e04. doi: 10.15420/aer.2024.03

What Cannot be Missed: Important Publications on Electrophysiology in 2023

Andrew Grace 1,✉, Gregory YH Lip 2, Pier D Lambiase 3,4, Sanjiv M Narayan 5, Hugh Calkins 6, Yutao Guo 7, Ken Ellenbogen 8, Demosthenes G Katritsis 6,9
PMCID: PMC10964293  PMID: 38544811

A list of the most important articles on arrhythmia published in 2023.

References

  • 1.Healey JS, Lopes RD, Granger CB et al. Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med. 2024;390:107–17. doi: 10.1056/NEJMoa2310234. [DOI] [PubMed] [Google Scholar]
  • 2.Kirchhof P, Toennis T, Goette A et al. Anticoagulation with edoxaban in patients with atrial high-rate episodes. N Engl J Med. 2023;389:1167–79. doi: 10.1056/NEJMoa2303062. [DOI] [PubMed] [Google Scholar]
  • 3.Sohns C, Fox H, Marrouche NF et al. Catheter ablation in end-stage heart failure with atrial fibrillation. N Engl J Med. 2023;389:1380–9. doi: 10.1056/NEJMoa2306037. [DOI] [PubMed] [Google Scholar]
  • 4.Knops RE, Reddy VY, Ip JE et al. A dual-chamber leadless pacemaker. N Engl J Med. 2023;388:2360–70. doi: 10.1056/nejmoa2300080. [DOI] [PubMed] [Google Scholar]
  • 5.Reddy VY, Gerstenfeld EP, Natale A et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023;389:1660–71. doi: 10.1056/nejmoa2307291. [DOI] [PubMed] [Google Scholar]
  • 6.Sau A, Kapadia S, Al-Aidarous S et al. Temporal trends and lesion sets for persistent atrial fibrillation ablation: a meta-analysis with trial sequential analysis and meta-regression. Circ Arrhythm Electrophysiol. 2023;16:e011861. doi: 10.1161/circep.123.011861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tan MC, Rattanawong P, Karikalan S et al. Causes of early mortality after catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2023;16:e011365. doi: 10.1161/circep.122.011365. [DOI] [PubMed] [Google Scholar]
  • 8.Tilz RR, Schmidt V, Purerfellner H et al. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J. 2023;44:2458–69. doi: 10.1093/eurheartj/ehad250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Al-Kaisey AM, Parameswaran R, Bryant C et al. Impact of catheter ablation on cognitive function in atrial fibrillation: a randomized control trial. JACC Clin Electrophysiol. 2023;9:1024–34. doi: 10.1016/j.jacep.2023.02.020. [DOI] [PubMed] [Google Scholar]
  • 10.Benali K, Khairy P, Hammache N et al. Procedure-related complications of catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2023;81:2089–99. doi: 10.1016/j.jacc.2023.03.418. [DOI] [PubMed] [Google Scholar]
  • 11.Lip GYH, Proietti M, Potpara T et al. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. Europace. 2023;25:euad226. doi: 10.1093/europace/euad226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Katritsis DG, Anderson RH. New insights into the mechanisms of fast and slow conduction in the atrioventricular node. Heart Rhythm. 2023;20:627–630. doi: 10.1016/j.hrthm.2022.08.025. [DOI] [PubMed] [Google Scholar]
  • 13.Higuchi S, Gerstenfeld EP, Hsia HH et al. Novel approaches for the diagnosis of concealed nodo-ventricular and His-ventricular pathways. Circ Arrhythm Electrophysiol. 2023;16:e011771. doi: 10.1161/circep.122.011771. [DOI] [PubMed] [Google Scholar]
  • 14.Aboud AA, Davogustto G, Adeola O et al. Substrate mapping alters ventricular tachycardia inducibility. Circ Arrhythm Electrophysiol. 2023;16:e010889. doi: 10.1161/circep.122.010889. [DOI] [PubMed] [Google Scholar]
  • 15.Waldmann V, Bessière F, Gardey K et al. Systematic electrophysiological study prior to pulmonary valve replacement in tetralogy of Fallot: a prospective multicenter study. Circ Arrhythm Electrophysiol. 2023;16:e011745. doi: 10.1161/circep.122.011745. [DOI] [PubMed] [Google Scholar]
  • 16.Kiani S, Sayegh MN, Ibrahim R et al. The feasibility and safety of flecainide use among patients with varying degrees of coronary disease. JACC Clin Electrophysiol. 2023;9:1172–80. doi: 10.1016/j.jacep.2022.12.021. [DOI] [PubMed] [Google Scholar]
  • 17.Friedman DJ, Al-Khatib SM, Dalgaard F et al. Cardiac resynchronization therapy improves outcomes in patients with intraventricular conduction delay but not right bundle branch block: a patient level meta-analysis of randomized controlled trials. Circulation. 2023;147:812–23. doi: 10.1161/circulationaha.122.062124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Vijayaraman P, Sharma PS, Cano Ó et al. Comparison of left bundle Important Publications on Electrophysiology in 2023 branch area pacing and biventricular pacing in candidates for resynchronization therapy. J Am Coll Cardiol. 2023;82:228–41. doi: 10.1016/j.jacc.2023.05.006. [DOI] [PubMed] [Google Scholar]
  • 19.Gaita F, Cerrato N, Giustetto C et al. Asymptomatic patients with Brugada ECG pattern: long-term prognosis from a large prospective study. Circulation. 2023;148:1543–55. doi: 10.1161/circulationaha.123.064689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Pokorney SD, Zepel L, Greiner MA et al. Lead extraction and mortality among patients with cardiac implanted electronic device infection. JAMA Cardiol. 2023;8:1165–73. doi: 10.1001/jamacardio.2023.3379. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Arrhythmia & Electrophysiology Review are provided here courtesy of Radcliffe Cardiology

RESOURCES